Access cutting-edge rhabdomyosarcoma treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Access rhabdomyosarcoma specialists in Memphis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rhabdomyosarcoma treatment provided free
This is a phase II study to determine safety and efficacy of combining liposomal irinotecan with vincristine alternating with VAC in intermediate-risk patients, liposomal irinotecan with temozolomide and vincristine alternating with VAC in high-risk patients and the chemotherapy combinations when given with concomitant radiation therapy in intermediate and high risk patients. Primary Objective * Estimate event-free survival for intermediate-risk participants treated with VAC and vincristine an
Sponsor: St. Jude Children's Research Hospital
Check if you qualify for this rhabdomyosarcoma clinical trial in Memphis, TN
If you're searching for rhabdomyosarcoma treatment options in Memphis, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rhabdomyosarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.